- Home
- BANL vs ABP Comparison
BANL vs ABP Comparison
Compare BANL & ABP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BANL
- ABP
- Stock Information
- Founded
- BANL 2015
- ABP 2004
- Country
- BANL Malaysia
- ABP United States
- Employees
- BANL N/A
- ABP N/A
- Industry
- BANL Oil Refining/Marketing
- ABP Biotechnology: Pharmaceutical Preparations
- Sector
- BANL Energy
- ABP Health Care
- Exchange
- BANL Nasdaq
- ABP Nasdaq
- Market Cap
- BANL 31.5M
- ABP 14.3M
- IPO Year
- BANL 2023
- ABP N/A
- Fundamental
- Price
- BANL $1.12
- ABP $0.27
- Analyst Decision
- BANL
- ABP Strong Buy
- Analyst Count
- BANL 0
- ABP 1
- Target Price
- BANL N/A
- ABP $4.00
- AVG Volume (30 Days)
- BANL 45.7K
- ABP 131.7K
- Earning Date
- BANL 04-16-2025
- ABP 05-18-2025
- Dividend Yield
- BANL N/A
- ABP N/A
- EPS Growth
- BANL N/A
- ABP N/A
- EPS
- BANL N/A
- ABP N/A
- Revenue
- BANL $521,173,543.00
- ABP $230,000.00
- Revenue This Year
- BANL N/A
- ABP N/A
- Revenue Next Year
- BANL N/A
- ABP N/A
- P/E Ratio
- BANL N/A
- ABP N/A
- Revenue Growth
- BANL 24.34
- ABP N/A
- 52 Week Low
- BANL $0.55
- ABP $0.23
- 52 Week High
- BANL $1.35
- ABP $13.00
- Technical
- Relative Strength Index (RSI)
- BANL 57.16
- ABP N/A
- Support Level
- BANL $0.80
- ABP N/A
- Resistance Level
- BANL $1.17
- ABP N/A
- Average True Range (ATR)
- BANL 0.10
- ABP 0.00
- MACD
- BANL 0.01
- ABP 0.00
- Stochastic Oscillator
- BANL 86.04
- ABP 0.00
About BANL CBL International Limited
CBL International Ltd is a company that provides a complete range of marine fuel logistics services. It sources the highest quality marine fuel from its trusted suppliers and ensures timely delivery to its customers. The company's expertise lies in providing a seamless and efficient one-stop solution for vessel refueling needs, making it a reliable partner for shipping companies. CBL International Ltd has a strong presence in China, Hong Kong, and Malaysia.
About ABP Abpro Holdings Inc Common Stock
Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms, The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with global pharmaceutical and research institutions.